Tricarboxylic acids and derivatives
![eMolecules 68-04-2 | Sodium citrate, anhydrous | Oakwood Chemical | MFCD00012462 | 258.068 | C6H5Na3O7 | 99.000 | [Na+].[Na+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O | 25g | 866847505](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000470643.jpg-250.jpg)
eMolecules 68-04-2 | Sodium citrate, anhydrous | Oakwood Chemical | MFCD00012462 | 258.068 | C6H5Na3O7 | 99.000 | [Na+].[Na+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O | 25g | 866847505
Sodium citrate, anhydrous | Oakwood Chemical | 68-04-2 | MFCD00012462 | 258.068 | C6H5Na3O7 | 99.000 | [Na+].[Na+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O | 25g | 866847505
Medchemexpress LLC 5,8,11,14,17,20-Hexaoxa-2-azadocosanedioic acid, 1-(9H-fluoren-9-ylmethyl) ester | 437655-96-4 | 99.4% | 1 G
Fmoc-NH-PEG6-CH2COOH is a cleavable linker used in the synthesis of antibody-drug conjugates (ADCs). It also functions as a PEG-based PROTAC linker, applicable in the synthesis of PROTACs. This compound facilitates the controlled degradation of target proteins by exploiting the intracellular ubiquitin-proteasome system.
- Cleavable linker for ADC synthesis
- PEG-based PROTAC linker
- Utilizes ubiquitin-proteasome system
- Enables selective degradation of target proteins
- Molecular weight of 561.62
- Formula C29H39NO10
- Appearance: colorless to light yellow liquid
- Soluble in DMSO (100 mg/mL)
Selleck Chemical LLC Amfenac Sodium Monohydrate S4149-1g
Amfenac Sodium monohydrate is a non-steroidal analgesic anti-inflammatory drug with acetic acid moiety The IC50 values for COX1 and COX2 is 250 nM and 150 nM respectively
Medchemexpress LLC IACS-8803 diammonium | 00-00-0 | 96.7% | C20H29FN12O9P2S2 | 10MG
IACS-8803 (diammonium) is a cyclic dinucleotide STING agonist supplied as a diammonium salt for research use. It potently activates the STING pathway and has demonstrated robust systemic antitumor efficacy in preclinical studies. The diammonium salt improves handling and stability compared with the free form and is intended for in vitro and in vivo immuno-oncology research.
- Potent STING pathway agonist for immune activation.
- Demonstrated systemic antitumor efficacy in preclinical models.
- Suitable for in vitro and in vivo research applications.
- Diammonium salt formulation for improved stability and handling.
- Requires cold-chain storage; research use only.
Medchemexpress LLC Oxolamine citrate (SKF-9976 citrate) | 1949-20-8 | 99.9% | 1 ML
Oxolamine citrate (SKF-9976 citrate) is an orally active antitussive that can inhibit CYP2B1/2 and has anti-inflammatory effects on the respiratory organs of guinea pigs. It increases the AUC of Warfarin and prolongs its terminal half-life. It can be used in respiratory disease research.
- Orally active antitussive
- Inhibits CYP2B1/2
- Has anti-inflammatory effects on the respiratory organs of guinea pigs
- Increases the AUC of Warfarin and prolongs its terminal half-life
- Can be used in respiratory disease research
Medchemexpress LLC Triammonium phosphate trihydrate | 25447-33-0 | MFCD00151223 | ≥98.0% | 203.13 | H18N3O7P | 100g
Triammonium phosphate trihydrate interacts with the magnesium ions to form a precipitate which can be used for magnesium separation from lithium in salt-lake brines[1]
Medchemexpress LLC Citrate synthase | 9027-96-7 | ~98 KDa dimer (49 KDa monomer) | 1000 U
Citrate synthase catalyzes the initial reaction of the citric acid cycle, facilitating the condensation of acetyl-CoA and oxaloacetate to produce citrate. This enzyme is primarily found within the mitochondrial matrix of eukaryotic cells.
- Catalyzes the condensation of acetyl-CoA and oxaloacetate
- Forms citrate, initiating the citric acid cycle
- Localized in the mitochondrial matrix of eukaryotic cells
- Specific activity of ≥100 U/mg protein
- Unit defined as 1.0 μmole of citrate formed per minute at pH 8.0 at 37°C
- Liquid appearance
- Colorless to light yellow
- Molecular weight of ~98 KDa dimer (49 KDa monomer)
Medchemexpress LLC Butamirate citrate | 18109-81-4 | MFCD00315222 | 99.9% | 499.6 g/mol | C24H37NO10 | 5 MG
Butamirate citrate is an orally active antitussive research compound supplied as the citrate salt. It acts centrally to suppress cough and has reported bronchodilatory and anti-inflammatory effects. Provided as a high-purity analytical standard for research use only.
- Orally active antitussive agent suitable for research.
- High purity analytical standard for assay and method development.
- Reported bronchodilatory and anti-inflammatory properties.
- Available in small packaged quantities for laboratory use.
- For research use only; not for human or clinical use.
Apexbio Technology LLC trans-Aconitic acid 4023-65-8 5g
trans-Aconitic acid (CAS 4023-65-8) is an unsaturated tricarboxylic acid endogenously detected in human urine It serves as a substrate for trans-aconitate 2-methyltransferase implicating it in metabolic pathways related to citrate metabolism Elevated urinary levels of trans-aconitic acid have been observed in conditions such as Reye s syndrome and certain organic acidurias suggesting its potential as a metabolic biomarker This compound is utilized in biomedical research to investigate metabolic dysregulation and to study enzyme-substrate interactions within organic acid metabolism
Medchemexpress LLC GS-443902 trisodium | 1355050-21-3 | 10MG
GS-443902 trisodium (GS-441524 triphosphate trisodium) is a potent viral RNA-dependent RNA-polymerases (RdRp) inhibitor with IC50s of 1 1 M 5 M for RSV RdRp and HCV RdRp respectively GS-443902 trisodium is the active triphosphate metabolite of Remdesivir (GS-5734)[1][2]
Medchemexpress LLC Azido-PEG6-CH2COOH | 880129-82-8 | ≥98.0% | 365.38 | 5 G
Azido-PEG6-CH2COOH is a PEG-based PROTAC linker used in the synthesis of PROTACs. It functions as a click chemistry reagent, enabling copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules and strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
- PEG-based PROTAC linker
- Suitable for synthesizing PROTACs
- Click chemistry reagent due to azide group
- Enables CuAAc reactions
- Participates in SPAAC reactions with DBCO or BCN groups
Medchemexpress LLC Acetic acid, 2-[2-(2-azidoethoxy)ethoxy]- | 882518-90-3 | 99.03% | 189.17 | 50 MG
Azido-PEG2-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. It is also a click chemistry reagent, containing an Azide group that can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups. This product is for research use only.
- Peg-based PROTAC linker
- Click chemistry reagent
- Contains an Azide group for CuAAc and SPAAC reactions
eMolecules 3458-72-8 | Ammonium citrate tribasic | Oakwood Chemicals243.216 | C6H17N3O7 | 99.000 | N.N.N.OC(=O)CC(O)(CC(O)=O)C(O)=O | 5g | 480150345
Ammonium citrate tribasic | Oakwood Chemicals | 3458-72-8243.216 | C6H17N3O7 | 99.000 | N.N.N.OC(=O)CC(O)(CC(O)=O)C(O)=O | 5g | 480150345
Medchemexpress LLC Acetic acid, 2-[2-(2-azidoethoxy)ethoxy]- | 882518-90-3 | 99.0% | 189.17 | 100 MG
Azido-PEG2-CH2COOH is a PEG-based PROTAC linker utilized in the synthesis of PROTACs. It functions as a click chemistry reagent, containing an Azide group that can participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with alkyne-containing molecules. It can also engage in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules possessing DBCO or BCN groups.
- Functions as a click chemistry reagent
- Contains an azide group
- Participates in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions
- Engages in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions
Medchemexpress LLC Fmoc-NH-PEG1-CH2COOH | 260367-12-2 | MFCD06796876 | 99.9% | 341.36 g·mol⁻¹ | C19H19NO5 | 25 G
Fmoc-NH-PEG1-CH2COOH is an Fmoc-protected PEG1 linker bearing a terminal carboxylic acid used as a cleavable linker in antibody-drug conjugate (ADC) synthesis and as a PEG-based PROTAC linker in conjugation chemistry. It has CAS number 260367-12-2, molecular formula C19H19NO5, and a molecular weight of 341.36 g·mol⁻¹.
- Cleavable ADC linker for antibody-drug conjugation.
- Suitable as a PEG-based PROTAC linker.
- Fmoc-protected amine enables standard peptide and solid-phase chemistries.
- High reported purity suitable for synthetic applications.
- Available in multiple pack sizes including 25 G for preparative work.